Tori Shepherd, a senior reporter at Guardian Australia, dives into the heated politics surrounding Australia's Pharmaceutical Benefits Scheme (PBS). She discusses how big pharma is pressuring Donald Trump for higher medicine prices, raising concerns about tariffs affecting Australian access to affordable medications. The conversation also highlights the stark price differences between the U.S. and Australia, the government's efforts to ensure low costs, and the implications for upcoming elections, all while addressing public misconceptions about the PBS.
